Pradaxa (dabigatran) is approved for the treatment of which of the following conditions?
A) Deep vein thrombosis
B) Pulmonary emboli
C) Atrial fibrillation
D) Prophylaxis for artificial heart valve

Question

Quizplus · Accepted Answer

Pradaxa (dabigatran) is approved for the treatment of atrial fibrillation, specifically for reducing the risk of stroke and systemic embolism. It is not approved for the treatment of deep vein thrombosis, pulmonary emboli, or prophylaxis for artificial heart valve.

Pradaxa (Dabigatran) Is Approved for the Treatment of Which of the Following